Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

ABSTRACT The Centers for Disease Control and Prevention (CDC) categorized carbapenem-resistant Enterobacterales (CRE) infections as an “urgent” health care threat requiring public attention and research. Certain patients with CRE infections may be at higher risk for poor clinical outcomes than other...

全面介紹

書目詳細資料

發表在:	Microbiology Spectrum
Main Authors:	Nicholas Rebold, Abdalhamid M. Lagnf, Sara Alosaimy, Dana J. Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J. Kunz Coyne, Amer El Ghali, Kaylee E. Caniff, Michael P. Veve, Michael J. Rybak
格式:	Article
語言:	英语
出版:	American Society for Microbiology 2023-02-01
主題:	carbapenem resistance Enterobacterales risk factors clinical failure ceftazidime-avibactam meropenem-vaborbactam
在線閱讀:	https://journals.asm.org/doi/10.1128/spectrum.02647-22